BioLogic Equity Research Starts Corcept Therapeutics (CORT) at Sell
CORT Hot Sheet
Rating Summary:3 Buy, 0 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 16 | Down: 7 | New: 23
BioLogic Equity Research initiates coverage on Corcept Therapeutics (NASDAQ: CORT) with a Sell.
For an analyst ratings summary and ratings history on Corcept Therapeutics click here. For more ratings news on Corcept Therapeutics click here.
Shares of Corcept Therapeutics closed at $3.44 yesterday, with a 52 week range of $2.51-$5.07.
Discover Wall Street's best ratings calls with the pros - Upgrade to Ratings Insider Elite. Free Trial!
For an analyst ratings summary and ratings history on Corcept Therapeutics click here. For more ratings news on Corcept Therapeutics click here.
Shares of Corcept Therapeutics closed at $3.44 yesterday, with a 52 week range of $2.51-$5.07.
Discover Wall Street's best ratings calls with the pros - Upgrade to Ratings Insider Elite. Free Trial!
You May Also Be Interested In
- UPDATE: Capstone Starts Facebook (FB) at Hold as Premium Multiple Not Justified
- Corcept Therapeutics (CORT) Files 4.2M Common Shelf for Shareholders
- Update - William Blair Initiates Coverage on Acquity Group (AQ) with an Outperform; Solid Performance with Secular Tailwinds
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
